Zoetis | ZTS - Operating Expenses

Stock Price
128.07
Daily Change
2.28 1.81%
Monthly
3.35%
Yearly
-22.53%
Q1 Forecast
124.79

Zoetis reported $1.55B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Align Technology USD 822.85M 11.8M Dec/2025
Bayer EUR 10.2B 523M Sep/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Coherus Biosciences USD 53.03M 43.41M Mar/2025
Dentsply International USD 1.48B 653M Sep/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Henry Schein USD 3.14B 77M Sep/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Illumina USD 903M 69M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Merck USD 10.16B 558M Dec/2025
Neogen USD 230.07M 4.79M Sep/2025
Pacira USD 166.36M 4.5M Sep/2025
Perrigo USD 949.9M 50.8M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Sanofi EUR 10.71B 1.32B Dec/2025
Zoetis USD 1.55B 3.85B Dec/2025